Signatera for detecting molecular residual disease from solid tumour cancers (MIB307)Product type:AdviceProgramme:Medtech innovation briefingPublished: 4 October 2022
Bladder EpiCheck for detecting bladder cancer recurrence (MIB293)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 May 2022
URO17 for detecting bladder cancer (MIB250)Product type:AdviceProgramme:Medtech innovation briefingPublished: 4 February 2021
ADXBLADDER for detecting bladder cancer (MIB180)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 April 2019